References
- Allington M.J. Detection of fibrin(ogen) degradation products by a latex clumping method. Scand. J. Haemat 1971; 115, Suppl. 13
- Chirawong P., Singh Nanra R., Kincaid Smith P. Fibrin degradation products and the role of coagulation in ‘persistent’ glomerulo-nephritis. Ann. intern. Med. 1971; 74: 853
- Clarkson A.R., MacDonald M.K., Petrie J.J.B., Cash J.D., Robson J.S. Serum and urinary fibrin/fibrinogen degradation products in glomerulonephritis. Brit. med. J. 1971; 3: 447
- Ekberg M., Bergentz S.-E., Hedner U., Nilsson I.M. Determination of fibrin/fibrinogen degradation products in concentrated urine after renal transplantation. Scand. J. Urol. Nephrol. 1976; 10: 56
- Ekberg M., Pandolfi M. Origin of urinary fibrin/fibrinogen degradation products in glo-merulonephritis. Brit. med. J. 1975; 2: 17
- Ekert H., Barratt T.M., Chantler C., Turner M.W. Immunologically reactive equiv-alentes of fibrinogen in sera and urine of children with renal disease. Arch. Dis. Childh. 1972; 47: 90
- Gordon Y.B., Martin M.J., McNeile A.T., Chard T. Specific and sensitive determination of fibrinogen-degradation products by radioimmunoassay. Lancet 1973; 2: 1168
- Hawiger J., Niewiarowski S., Gurewich V., Thomas D.P. Measurement of fibrinogen and fibrin degradation products in serum by staphylococcal clumping test. J. Lab. clin. Med. 1970; 75: 93
- Hedner U. Urinary fibrin/fibrinogen degradation products (FDP) in renal diseases and during thrombolytic therapy. Scand. J. clin. Lab. Invest. 1973; 32: 175
- Hedner U., Ekberg M., Nilsson I.M. Urinary fibrin/fibrinogen degradation products (FDP) and glomerulonephritis. Acta. med. scand. 1974; 195: 81
- Laurell C.B. Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies. Analyt. Biochem. 1966; 15: 45
- McDonagh J., Messel H., McDonagh R.P., Jr., Murano G., Blombäck B. Molecular weight analysis of fibrinogen and fibrin chains by an improved sodium dodecul sulfate gel electrophoresis method. Biochim. biophys. Acta (Amst.) 1972; 257: 135
- Marder V.J., Shulman N.R. High molecular weight derivatives of human fibrinogen produced by plasmin. II. Mechanism of their anticoagulant activity. J. biol. Chem. 1969; 244: 2120
- Melliger E.J. Detection of fibrinogen degradation products by use of antibody coated latex particles. Thrombos. Diathes. haemorrh. (Stuttg.) 1970; 23: 211
- Merskey C., Johnson A.J., Lalezari P. Increase in fibrinogen and fibrin-related antigen in human serum due to in vitro lysis of fibrin by thrombin. J. clin. Invest. 1972; 51: 903
- Naish P.F., Sevitt L.H., Pitney W.R., Peters D.K. Fibrinogen derivatives in renal disease. Clin. Sci. 1970; 39: 15
- Niléhn J.-E. Separation and estimation of ‘split products’ of fibrinogen and fibrin in human serum. Thrombos. Diathes. haemorrh. (Stuttg.) 1967; 18: 487
- Pizzo S.V., Schwartz M.L., Hill R.L., McKee P.A. The effect of plasmin on the subunit structure of human fibrinogen. J. biol. Chem. 1972; 247: 636
- Plow E., Edgington T.S. Immunobiology of fibrinogen. Emergence of neoantigenic expressions during physiologic cleavage in vitro and in vivo. J. clin. Invest. 1973; 52: 273
- Plow E., Edgington T.S. Discriminating neoantigenic differences between fibrinogen and fibrin derivatives. Proc. nat. Acad. Sci. (Wash.) 1973; 70: 1169
- Starzl T., Lerner R., Dixon F., Groth C., Brettschneider L., Terasaki P. Shwartzman reaction after human renal homotransplanta-tion. New Engl. J. Med. 1968; 278: 642
- Stiehm F.R., Kuplic L.S., Uehling D.T. Urinary fibrin split products in human renal disease. J. Lab. clin. Med. 1971; 77: 843
- Svanberg L., Hedner U., Åstedt B. Value of determination of F. D. P. during pregnancy by immunochemical and latex agglutination inhibition methods. Acta obstet. gynec. scand. 1974; 53: 91
- Thorell J.I., Johansson B.G. Enzymatic iodination of polypeptides with 125I to high specific activity. Biochim. biophys. Acta (Amst.) 1971; 251: 363